Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Number of holders
-
290
-
Total 13F shares, excl. options
-
64,356,332
-
Shares change
-
+2,114,709
-
Total reported value, excl. options
-
$2,890,283,528
-
Value change
-
+$83,553,842
-
Put/Call ratio
-
48%
-
Number of buys
-
146
-
Number of sells
-
140
-
Price
-
$44.95
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2022
As of 31 Dec 2022 TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) had 290 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,356,332 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Champlain Investment Partners, LLC, EMINENCE CAPITAL, LP, BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, Bellevue Group AG, and Capital International Investors.
This table shows 290 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.